As shown in a companion paper, the mutagenicity of two treatments (BS and BP) was significantly greater than the mutagenicity of the untreated soil. Mutagenic fractions (>500 revertants) were analyzed by gas chromatography/mass spectrometry (GC/MS). PAH analysis of the soils indicated that all treatments were effective in reducing the total PAH concentration (48-74%). Qualitative GC/MS analysis of the mutagenic fractions from the BS and BP treatments indicated that they contained azaarenes, which are mutagens. The CMP and LT processes were the most effective and least toxic bioremediation procedures based on mutagenic potency and chemical analysis. This research demonstrated that the combination of bioassays and chemical analysis provided a more accurate determination of toxicity in these complex environmental mixtures.
mutagenicity
There are over 700 wood-preserving facilities documented in the United States (1, 2) . Many designated Superfund sites are a result of wood treatment activities involving creosote (1, 2) . During the pressure treatment of wood products, excess creosote is released from the treated materials, and the leaching of creosote wastes from treated materials contaminating the soil and groundwater has been common (1, 2) . One such contaminated site is in St. Louis Park, Minnesota, the former site of the Reilly Tar and Chemical Corporation's coal tar distillation and wood preserving plant. From 1917 to 1972, dumping from this plant contaminated about 80 acres of soil and the underlying groundwater with creosote wood-preserving waste (3) . In 1978, the Minnesota Department of Health discovered significant concentrations of polycyclic aromatic hydrocarbons (PAHs) in six municipal drinking water wells near the Reilly Tar Site plant (3) . Currently, St. Louis Park is pumping and treating the contaminated groundwater plume leaching from the creosote-contaminated soil and has placed a soil cover with grass over the contaminated soil.
To reduce the length of time required for pump and treat operations, the U.S. Environmental Protection Agency (U.S. EPA) National Risk Management Research Laboratory (Cincinnati, Ohio) is evaluating various bioremediation technologies for their efficiency in removing PAHs and reducing toxicity of soil collected from St. Louis Park. The bioremediation technologies that are being examined in pilot-scale laboratory studies are bioslurry (BS), biopile (BP), compost (CMP), and land treatment (LT). These technologies are presented and described by Hughes et al. (4) . The goal of these bioremediation technologies is to reduce the PAH concentrations and toxicity of contaminated soils. The PAH concentrations were chemically monitored throughout this study. The mutagenic activity of the soil extracts was measured in the untreated soil (UTS) and in the four treatment soils at end of the study. Mutagenic activity was measured using the Salmonella mutagenicity assay developed by Maron Higher-ring PAHs take longer to be degraded (10) because of the induction of complex biodegradation enzymes in microorganisms, low solubility, and sorption to the soil. The largest average reduction in total PAHs for the four extracts tested in the mutagenicity assay was in the CMP (74%), followed by the BS (62%), LT (62%), and BP treatments (48%).
After the bioassay of each fraction was completed, the resulting mutagenicity profile of the HPLC fractions constituted a mutagram (11) . Mutagrams from all four bioremediation treatments, UTS, and a solvent (DCM) method blank, bioassayed in the Salmonella mutagenicity assay in YG1041 +S9 and -S9, are shown in Figures 1 and 2 . The average mutagenicity of the solvent blank fractions was 138 ± 55 rev +S9 and 131 ±41 rev -S9. A treatment fraction was not considered mutagenic unless it was . 500 rev (greater than three times the solvent blank) per fraction. The BS treatment had the most mutagenic fractions (both revertants per fraction and the number of fractions) both +S9 and -S9. The BP treatment showed less mutagenicity (both revertants per fraction and the 
Discussion
It has been estimated that creosote consists of 85% PAHs, 10% phenolics, and 5% other N-, S-, and O-heterocyclics (1). In this study, the bioremediation treatments (BP, BS, CMP, and LT) were successful in reducing the priority pollutant PAHs by 48% or more (Table 1) . However, when the soil extracts from the bioremediation treatments and the UTS (extracted at the same time as the treatment soils) were tested in the Salmonella mutagenicity assay in strain YG1041, two treatments (BS and BP) had increased mutagenic activity, both with and without S9 addition, when compared to UTS (4) . All four bioremediation treatments and the UTS were fractionated by HPLC and tested in a microsuspension modification of the Salmonella mutagenicity assay using strain YG1041, which yielded mutagrams (Figures 1 and 2) . Again, the two treatments (BS and BP) had increased mutagenicity as compared to the UTS, especially in 11 of 40 fractions of the BS (+S9, -S9) and in 6 fractions of the BP (+S9, -S9) (Figures 1 and 2) .
To determine the cause of the increased mutagenicity in these two treatments, the mutagenic HPLC fractions, along with corresponding fractions from the UTS, were analyzed by GC/MS. Of the 11 mutagenic fractions of the BS and BP treatments analyzed by GC/MS, only 3 fractions contained any of the priority pollutant PAHs ( Table 1 ). The mutagenicity (+S9) seen in fractions 30 and 31 of the BS and BP treatments is likely due to PAHs that are positive in the Salmonella mutagenicity assay (Table 3 ). The mutagenicity in other fractions, therefore, must be attributed to compounds other than the 19 priority PAHs. Many of the other compounds identified by GC/MS in the fractions are azaarenes (i.e., PAHs where a nitrogen replaces a carbon in the ring structure). Several of these azaarenes (acridine, 1-azapyrene, diaminotriazole, and methylazaphenanthrene) are mutagenic -S9 (Table 3) .
Nitroarenes are another class of chemicals that were of concern in these samples. Many nitroarenes (i.e., a nitro group attached to a PAH) are direct-acting mutagens (i.e., they do not need S9 to be mutagenic). For a review of their mutagenicity see Rosenkranz and Mermelstein (17) (12, 16) aResults are shown only for the mutagenic fractions. bCompounds in italics are azaarenes.
acetyltransferase. Salmonella strains YG1 041 and YG 1042 were developed from the standard Salmonella tester strains TA98 and TAIOO (5), respectively, and they contain elevated levels (50 x) of both nitroreductase and acetyltransferase activities (7 (Table 2 ) and may have been increased in the BS by the addition of the activated sludge. For example, acridine, 1-azapyrene, diaminotriazole, and methylazaphenanthrene were uniquely identified in the BS. All have been cited as directacting mutagens (Table 3 ). The mutagenic fractions for the BS in Figure 2 may be due to these compounds and the higher number of PAHs in the BS. In addition, acridine, fluorescein (dyes), and tetrachloroethane (an industrial product) were identified in BS fractions 31, 18, and 24, respectively. The presence of these three compounds may be evidence that the activated sludge added to the BS contained industrial chemicals.
Another possible reason the BS was more mutagenic than the other treatments was that the BS was the only treatment that was constantly aerated and mixed. The BS had air bubbled to the bottom of the reaction vessels at the rate of 1.5 ml/min and was stirred at 500 rpm (4 occur. CMP had 1% cow manure added, but the treatment vessel was not aerated, and was mixed once a day by rolling the vessel for 30 min. LT had nothing added and was tilled once per week. Each of these processes, therefore, had different levels of anaerobic and aerobic metabolism occurring. The differences in aeration, mixing, and addition of sludge/manure between the mutagenic treatments (BS, BP) and the other nonmutagenic treatments (CMP, LT) may account for the mutagenicity. Weak mutagenic activity was also detected in all five extracts in TA102 (4). This strain detects mutagenic aldehydes and ketones, which were detected in the BS and BP (Table 2 ).
Conclusion
The pilot scale laboratory experiments of the creosote-contaminated field soil were conducted to determine which treatment was most successful not only in reducing the total PAH concentration but also the toxic potential of this soil. The PAH analysis demonstrated that each treatment was successful in reducing the total PAH concentration. However, the mutagenic activity demonstrated that some treatments (BP and BS) actually increased the toxic potential of these soils. Also, chemical analysis along with the bioassay identified several problems. The initial PAH concentrations (Table 1) varied among the treatments and were due to the different sieving sizes (1/4 to 1 in) used for each of them. In the future, uniform particle sizes should be used to more accurately compare the treatments. Also, the increased mutagenicity in the treatments (BP and BS) could not be directly associated with the amendments (i.e., activated sludge) added to these treatments because they were not analyzed directly in the chemical analysis and the mutagenicity assay. Amendments should be evaluated for toxicity before addition to a bioremediation process to ensure that they are nontoxic. Complex environmental mixtures such as these soil extracts can contain hundreds of chemicals. Bioassaydirected fractionation is an efficient method to identify signature mutagenic chemicals in such mixtures. The combination of bioassays and chemical analysis provided a more complete and accurate evaluation of the four bioremediation treatments in this pilot study.
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